Literature DB >> 26247060

METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS.

C Racine1, M Vincent1, A Rogers2, M Donat1, N I Ojike2, O Necola3, E Yousef3, A Masters-Israilov3, G Jean-Louis2, S I McFarlane3.   

Abstract

BACKGROUND: Increased legalization of marijuana has resulted in renewed interest in its effects on body weight and cardiometabolic risk. Conflicting data exist regarding marijuana effects on body weight, waist circumference as well as lipid profiles, blood pressure and cardiovascular disease. Furthermore, there is a dearth of data available on this effect in the black population.
OBJECTIVE: To assess the metabolic profile and cardiovascular risk factors as well as body weight and waist circumference among urban black marijuana users.
METHODS: A cross sectional study design involving 100 patients seen in a Family Practice clinic at University hospital of Brooklyn, NY, USA, over a period of 3 months from January 2014 to March 2014. Participants were administered a questionnaire regarding marijuana use, and other associated behaviors. Socio-demographic, laboratory, and clinical data were collected. We report measures of central tendencies, and dispersion for continuous variables and the frequency of distribution for categorical variables.
RESULTS: Of the 100 patients surveyed, 57% were females. The mean (±SEM) age of the entire cohort was 46.3 years±1.5; range, 19-78 years. The mean body mass index (BMI) was 29.6 kg/m2±0.73; SBP=128.0 mmHg±1.69; DBP=76.1 mmHg±1.17. Current marijuana users had the lowest waist circumference compared to former or never users respectively (32.9±0.66 vs. 35.9±0.88 vs. 33.4±0.74), p<0.01. Diastolic blood pressure in mmHg was significantly higher among former marijuana users compared to current or never users, (80.0±2.1 vs. 73.3±2.3 vs. 73.4±1.6), p<0.01. Current marijuana users showed a tendency (not statistically significant) towards lower total cholesterol, Triglycerides (TG), High Density Lipoprotein (HDL)-cholesterol, Low Density Lipoprotein (LDL)-cholesterol, body mass index (BMI) and systolic blood pressure, compared to former users or never users.
CONCLUSION: Current marijuana use is associated with significantly lower waist circumference, compared to former users and never users. Except for diastolic BP that was significantly lower among current users, other metabolic parameters showed tendency towards favorable profile. Further studies are needed to characterize the metabolic effects and to elucidate mechanisms of actions of marijuana in view of its rapid rate of utilization in the USA and around the world.

Entities:  

Keywords:  Marijuana; black population; body weight; metabolic risk factors

Year:  2015        PMID: 26247060      PMCID: PMC4523241     

Source DB:  PubMed          Journal:  J Dis Glob Health


  21 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  [Enlarged waist circumference and cardiovascular risk factors].

Authors:  Zoltan Pataky; Elisabetta Bobbioni-Harsch; Vincent Makoundou; Alain Golay
Journal:  Rev Med Suisse       Date:  2009-03-25

Review 3.  A review of the world cannabis situation.

Authors:  T Leggett
Journal:  Bull Narc       Date:  2006

4.  Explaining the recent decline in marijuana use: differentiating the effects of perceived risks, disapproval, and general lifestyle factors.

Authors:  J G Bachman; L D Johnston; P M O'Malley; R H Humphrey
Journal:  J Health Soc Behav       Date:  1988-03

5.  Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study).

Authors:  Nicolas Rodondi; Mark James Pletcher; Kiang Liu; Stephen Benjamin Hulley; Stephen Sidney
Journal:  Am J Cardiol       Date:  2006-06-19       Impact factor: 2.778

6.  [Smoking cessation and prevention of weight gain].

Authors:  Luc Seignol; Coralie Noel Huert Bas
Journal:  Rev Infirm       Date:  2013-12

7.  Smoking cessation and weight gain in patients with cardiovascular disease or risk factor.

Authors:  Jaqueline S Issa; Paulo C J L Santos; Lis P Vieira; Tania O Abe; Carla S Kuperszmidt; Miyoko Nakasato; Elisabeth Cardoso; Clarice Amorim; Alexandre C Pereira
Journal:  Int J Cardiol       Date:  2014-01-22       Impact factor: 4.164

Review 8.  Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors.

Authors:  Eli V Gelfand; Christopher P Cannon
Journal:  J Am Coll Cardiol       Date:  2006-04-24       Impact factor: 24.094

Review 9.  Metabolic obesity: the paradox between visceral and subcutaneous fat.

Authors:  Osama Hamdy; Sriurai Porramatikul; Ebaa Al-Ozairi
Journal:  Curr Diabetes Rev       Date:  2006-11

10.  Analysis of factors that determine weight gain during smoking cessation therapy.

Authors:  Maki Komiyama; Hiromichi Wada; Shuichi Ura; Hajime Yamakage; Noriko Satoh-Asahara; Akira Shimatsu; Hiroshi Koyama; Koichi Kono; Yuko Takahashi; Koji Hasegawa
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

View more
  7 in total

1.  Chronic marijuana use moderates the correlations of serum cholesterol with systemic mitochondrial function and fluid cognition.

Authors:  Jun Panee; Viola Pomozi; Adrian A Franke; Olivier Le Saux; Mariana Gerschenson
Journal:  Mitochondrion       Date:  2020-03-10       Impact factor: 4.160

2.  Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012.

Authors:  Omayma Alshaarawy; Hosam A Elbaz
Journal:  J Hypertens       Date:  2016-08       Impact factor: 4.844

3.  Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men.

Authors:  Madeline H Meier; Dustin Pardini; Jordan Beardslee; Karen A Matthews
Journal:  Psychosom Med       Date:  2019-04       Impact factor: 4.312

4.  Associations of Taste Perception with Tobacco Smoking, Marijuana Use, and Weight Status in the National Health and Nutrition Examination Survey.

Authors:  Ariana M Chao; Yingjie Zhou; Alexis T Franks; Brianna E Brooks; Paule V Joseph
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 3.160

Review 5.  A commentary on the medicinal use of marijuana.

Authors:  Gehad Mohamed Tawfik; Mohammad Rashidul Hashan; Abdelaziz Abdelaal; Thuan Minh Tieu; Nguyen Tien Huy
Journal:  Trop Med Health       Date:  2019-05-24

Review 6.  Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.

Authors:  Thomas Murphy; Bernard Le Foll
Journal:  Biomolecules       Date:  2020-06-04

7.  Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights.

Authors:  Justin Lee; Navneet Sharma; Farnam Kazi; Irini Youssef; Alyson Myers; Jonathan D Marmur; Moro O Salifu; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2017-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.